Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA

MS Treatments

Jahr

Publikationsjahr
2018

Autoren

Autorenliste der Publikation
Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Medin J, Cornelissen C; PANGAEA study group.

Verlag

Publisher-Information
Neurotherapeutics. 2018 Jan;15(1):190-199.

Link

Zur Publikation (externer Server)
https://doi.org/10.1007/s13311-017-0595-y

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2018